Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Bhagwat

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Advances in Experimental Medicine and Biology|June 1, 2017
Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular AnalysisNeha Bhagwat, Erica L Carpenter
Science Translational Medicine|October 22, 2010
Metabolic syndromes and malignant transformation: where the twain shall meetNeha Bhagwat, Ross L Levine
International Journal of Hematology|May 15, 2013
Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasmsNeha Bhagwat, Ross L Levine, Priya Koppikar
The Journal of Biological Chemistry|August 30, 2007
Identification of a novel lysophospholipid acyltransferase in Saccharomyces cerevisiaeShilpa Jain, NaTaza Stanford, Neha Bhagwat, et al.
Frontiers in Oncology|February 19, 2024
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancerNorman Fultang, Ashley M Schwab, Sophia McAneny-Droz, et al.
Blood|August 14, 2014
Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesisSara C Meyer, Matthew D Keller, Brittany A Woods, et al.
Cancer Research|May 9, 2018
miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic CancerJina Ko, Neha Bhagwat, Taylor Black, et al.
Lab on a Chip|August 16, 2017
A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysisJina Ko, Neha Bhagwat, Stephanie S Yee, et al.
Cancer Research Communications|October 20, 2023
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and ChemotherapiesJack Carter, Michael Hulse, Monisha Sivakumar, et al.
Haematologica|August 16, 2019
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasmsKaitlyn Shank, Andrew Dunbar, Priya Koppikar, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|June 1, 2017
Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular AnalysisNeha Bhagwat, Erica L Carpenter
Science Translational Medicine|October 22, 2010
Metabolic syndromes and malignant transformation: where the twain shall meetNeha Bhagwat, Ross L Levine
International Journal of Hematology|May 15, 2013
Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasmsNeha Bhagwat, Ross L Levine, Priya Koppikar
The Journal of Biological Chemistry|August 30, 2007
Identification of a novel lysophospholipid acyltransferase in Saccharomyces cerevisiaeShilpa Jain, NaTaza Stanford, Neha Bhagwat, et al.
Frontiers in Oncology|February 19, 2024
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancerNorman Fultang, Ashley M Schwab, Sophia McAneny-Droz, et al.
Blood|August 14, 2014
Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesisSara C Meyer, Matthew D Keller, Brittany A Woods, et al.
Cancer Research|May 9, 2018
miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic CancerJina Ko, Neha Bhagwat, Taylor Black, et al.
Lab on a Chip|August 16, 2017
A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysisJina Ko, Neha Bhagwat, Stephanie S Yee, et al.
Cancer Research Communications|October 20, 2023
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and ChemotherapiesJack Carter, Michael Hulse, Monisha Sivakumar, et al.
Haematologica|August 16, 2019
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasmsKaitlyn Shank, Andrew Dunbar, Priya Koppikar, et al.
Pageof 4